Psychedelic Stocks,Shroom News Silo Wellness Signs a Patent Agreement of Psilocybin Nasal Spray with Jungle Med By Dennis Mutua April 16, 2021 Psychedelics focused wellness company Silo Wellness Inc. (CSE: SILO) announced having entered an intellectual property licensing agreement of psilocybin with Jungle Med Inc. to exclusively produce, advertise, promote, and distribu...
Spotlight Stock,Trends & Articles PsyBio Submits Application to get Listed on OTCQX Market By Dennis Mutua April 15, 2021 Biotechnology company developing new class of drugs with psychoactive compounds PsyBio Therapeutics Corp (CVE: PSYB) has submitted its application to get its subordinate voting shares listed for trading on the OTCQX market. OTC...
Featured,Shroom News Psychedelics Bill Authorized by Senator Scott Weiner Passed by Senate Health Committee By Dennis Mutua April 15, 2021 United States Senate Health Committee passed a bill aimed at decimalizing use of psychedelics drugs authorized by the Senator of San Francisco Scott Weiner. The committee voted 6:1 in favor of the psychedelics bill. Senator Wei...
Featured,Spotlight Stock,Trends & Articles Mydecine Announces Breakthrough in Research of Chemical Compounds and Therapeutic Effects of Natural Psilocybin By Dennis Mutua April 14, 2021 Biotech and life sciences company specializing in developing innovative solutions for mental illnesses Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) announced having reached a key milestone in its ongoing research geared tow...
Psychedelic Stocks,Shroom News Research Shows Psilocybin May be Used for its Antidepressant Properties Without Any Psychedelic Experiences By Dennis Mutua April 14, 2021 A recent study conducted by the University of Maryland shows how psilocybin can be used for its antidepressant properties without the need of the user having any prior experience with psychedelics. This research was financed by...
Featured,Shroom News,Spotlight Stock Awakn Unveils New Digital Unit Focused on Improving the Effectiveness of Psychedelics Therapy By Dennis Mutua April 13, 2021 Clinical biotechnology company majoring on researching, developing, and delivering psychedelic new molecular drugs Awakn Life Sciences Inc. has unveiled a new digital wing which will be focusing on using advanced analytics to impr...
Psychedelic Stocks,Trends & Articles Mind Cure Health Files for Provisional Patent for Propriety Digital Therapeutics By Dennis Mutua April 13, 2021 Mental health and wellness company focused on investigation of psychoactive, psychedelic, and nootropic compounds, Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) has filed for provisional patent with the United States Patent and...
Featured,Spotlight Stock,Trends & Articles Creso Pharma Acquiring Halucenex Life Sciences to Explore Genome Sequencing of Magic Mushroom By Dennis Mutua April 12, 2021 Pharmaceutical company developing cannabis extracted therapeutic, nutraceutical, and lifestyle products for human health Creso Pharma Ltd. (ASX: CPH) announced having entered an agreement to acquire psychedelics focused pharmaceut...